China’s newly adopted Cosmetics Supervision and Administration Regulation could mean less animal testing and speedier approval of new ingredients, according to Francine Lamoriello of the Personal Care Products Council. Coming implementing regulations, standards and guidances should help to provide needed clarity, she says.

FDA’s second report to Congress on oversight of CBD market includes results from studies of whether products are mislabeled or adulterated, but also indicates throughout that more data are needed on safety of hemp-derived CBD ingredients used in myriad consumer health, cosmetic and food products already available.

Marketers of cosmetic products that rely on prostaglandins or their analogues to grow eyelashes – or compete against companies that use the ingredients – have until 22 October to submit information to the Commission, which will help inform an assessment by the Scientific Committee on Consumer Safety.

“How well do we understand the complex sector that supports every facet of our life?” asks Cosmetics Europe’s website for the “Essentials for Daily Life” film series co-developed with the trade association’s members in partnership with BBC StoryWorks Commercial Productions. 

Leave-on cosmetics and their manufacturers are virtually certain to take significant hits under the European Chemicals Agency’s developing microplastic restriction. As ECHA committees prepare to publish opinions on the matter, the big question for cosmetic stakeholders is just how costly and disruptive the measure will be.

In January, the Evergreen State was considering targeting phthalates in perfumes, colognes and body mists and sprays for alternatives analyses and potential regulatory action under its California-esque Safer Products program. More than 1,300 stakeholder comments later, the Department of Ecology is proposing that general use of phthalates in cosmetic products warrants a look.

FDA’s second report to Congress on oversight of CBD market includes results from studies of whether products are mislabeled or adulterated, but also indicates throughout that more data are needed on safety of hemp-derived CBD ingredients used in myriad consumer health, cosmetic and food products already available.

L’Oreal acquires Thayers Natural Remedies; Unilever, L’Oreal remove ‘whitening,’ ‘fair’ from labels; China finalizes modernization of cosmetics regulations; and Florida governor signs law preventing local bans on oxybenzone.

“Nine of the chemicals we are proposing to ban in AB 2762 are linked to a compromised immune system which can increase susceptibility to, and negatively impact recovery from, COVID-19,” Assemblymember and coauthor Bill Quirk says of the Toxic-Free Cosmetics Act, which passed California’s Assembly unanimously on 11 June.

Legislation also provides the US Biomedical Advanced Research and Development Authority with $3.5bn to advance research and development, manufacturing, production and the purchase of vaccines and therapeutics.

The California Toxic-Free Cosmetics Act passed out of the State Assembly Committee on Environmental Safety and Toxic Materials on 14 May. A far cry from the original draft of the bill, AB 2762 would ban more than a dozen cosmetic ingredients in California whose use is prohibited already in Europe.

ACI’s James Kim, vice president of science and regulatory affairs, provides an overview of the cleaning product industry’s ongoing efforts to fill GRASE data gaps previously identified by the US FDA, which the trade group expects to be reasserted under newly legislated FDA administrative order procedures.

Like other hand sanitizer manufacturers, WillSpeed Technology claims its GermBloc “kills 99.99% of germs.” Plaintiffs in a proposed class action filed in Massachusetts federal court allege the claim “grossly overstates” the product’s efficacy, deceiving consumers and endangering them with false confidence.

L’Oreal USA beat a suit in May in New York regarding liquid cosmetics packaging, which plaintiffs alleged cheated consumers out of product they expected to be accessible, only to face a newly proposed class action, filed in California on 5 June, over an alleged Clarisonic waterproofing defect.

Legal experts note that J&J’s decision to end Johnson’s Baby Powder sales in the US and Canada closely followed a New Jersey federal court decision that largely denied the firm’s motions to bar testimony from plaintiff experts in multi-district talc litigation comprising around 16,000 cases.

The iconic talc-based product will no longer be available for purchase in the US and Canada after supplies run out. Standing firm on the safety of Johnson’s Baby Powder, J&J attributes the move to declining demand due to changing consumer habits, misinformation “and a constant barrage of litigation advertising.”

Huda Beauty clearly intends for its Neon Obsession color palettes to be used as eyeshadow, despite a “hidden disclaimer” contraindicating the products for eye-area use, according to the plaintiff in a proposed class action filed in California’s Central District.

After five and a half years, three dismissal motions and one appeal, Beiersdorf’s prevailed on 15 April by summary judgment in a proposed class action alleging that its Nivea Skin Firming Hydration Body Lotion is an unlawfully marketed drug. Of course, the plaintiff still could appeal.